Epoch Investment Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Epoch Investment Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-169,941	Closed	-$8.01M	–	445
2022 Q3	$8.01M	Buy	+169,941	New	+$11M	0.05%	276
2022 Q1	–	Sell	-362,641	Closed	-$37.2M	–	470
2021 Q4	$37.2M	Sell	362,641 -96,787	-21%	-$9.29M	0.19%	160
2021 Q3	$40.2M	Sell	459,428 -5,005	-1%	-$453K	0.22%	139
2021 Q2	$41.6M	Buy	464,433 +296,101	+176%	+$25M	0.22%	136
2021 Q1	$12.8M	Buy	+168,332	New	+$12.7M	0.06%	227

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Epoch Investment Partners's SYNH Position: Q4 2022 in Review

Epoch Investment Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 169,941 shares — an estimated $8.01M sold.

Epoch Investment Partners first reported a position in SYNH in Q1 2021 and held it in 5 quarters. The position peaked at $41.6M in Q2 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Epoch Investment Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Epoch Investment Partners sold 169,941 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $8.01M.
Epoch Investment Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Epoch Investment Partners's Syneos Health, Inc. Class A Common Stock position peaked at $41.6M in Q2 2021.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Epoch Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.